TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Nordic Biomarker AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 (consolidated) |
Turnover |
82,169
|
86,621
|
95,066 |
Financial expenses |
1,363
|
1,205
|
284 |
Earnings before taxes |
-27,353
|
-16,914
|
-7 |
EBITDA |
-18,204
|
-9,659
|
8,723 |
Total assets |
109,707
|
139,058
|
126,397 |
Current assets |
46,532
|
47,454
|
53,227 |
Current liabilities |
53,938
|
47,550
|
26,786 |
Equity capital |
50,684
|
90,407
|
72,136 |
- share capital |
101
|
100
|
109 |
Employees (average) |
69
|
75
|
66 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 (consolidated) |
Solvency |
46.2%
|
65.0%
|
57.1% |
Turnover per employee |
1,191
|
1,155
|
1,440 |
Profit as a percentage of turnover |
-33.3%
|
-19.5%
|
0.0% |
Return on assets (ROA) |
-23.7%
|
-11.3%
|
0.2% |
Current ratio |
86.3%
|
99.8%
|
198.7% |
Return on equity (ROE) |
-54.0%
|
-18.7%
|
0.0% |
Change turnover |
-4,898
|
-744
|
15,848 |
Change turnover % | -6% | 20% | |
Chg. No. of employees |
-6
|
9
|
10 |
Chg. No. of employees % | -8% | 18% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.